Adlea

Anesiva Announces Going Concern Opinion and Nasdaq Notice

...ent of acute pain following orthopedic surgeries. adlea has been shown in clinical trials to provide exten...Anesiva announced that a Phase 3 clinical trial of adlea achieved its primary efficacy endpoint of reduced ...The trial also met its key secondary endpoint with adlea demonstrating a highly significant reduction in op...

Anesiva Announces Planned Rights Offering

...ment of acute pain following orthopedic surgeries. adlea has been shown in clinical trials to provide exten...Anesiva announced that a Phase 3 clinical trial of adlea achieved its primary efficacy endpoint of reduced ...The trial also met its key secondary endpoint with adlea demonstrating a highly significant reduction in op...

Adlea in Medical Technology

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring

Conference Call Scheduled for November 11, 2008 at 9:00 am ET SOUTH SAN FRANCISCO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) today announced that the ACTIVE-1 Phase 3 trial evaluating Adlea(TM), a novel formulation of capsaicin, narrowly missed its primary e...

Anesiva Defines Regulatory Pathway for Adlea with FDA

New Phase 3 Plan Could Expedite Clinical Development Pathway SOUTH SAN FRANCISCO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) today announced that it will conduct two Phase 3 clinical trials for the approval of Adlea(TM) -- one of which has already been plann...

Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication

...ment of acute pain following orthopedic surgeries. adlea has been shown in clinical trials to provide exten...er 2008, Anesiva announced that a Phase 3 trial of adlea achieved its primary efficacy endpoint of reduced ...The trial also met its key secondary endpoint with adlea demonstrating a highly significant reduction in op...

Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company

...uses Operations, Updates Zingo Launch Progress and adlea Registration Strategy ...ress, announced the full enrollment of its Phase 3 adlea clinical trials and provided an update on its adlea registration strategy. "Since joining Anesiva in...

Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery

... shoulder surgery involving rotator cuff repair. adlea is currently in two pivotal Phase 3 trials in the ...e in bunionectomy surgeries. An additional Phase 2 adlea trial is in progress in total hip replacement surg...hese trials are among those intended to support an adlea label indication for the management of acute pain ...

Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application

...siva plans to initiate a Phase 2 clinical trial of adlea in patients undergoing arthroscopic shoulder surge...a this summer. "We selected South Korea for this adlea clinical trial because the standards of care in or...ry. The trial is designed to enroll 74 patients. adlea is currently in two pivotal Phase 3 trials in the ...

Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement

...safety and efficacy of a single 5 or 15 mg dose of adlea or placebo administered into the surgical site in ...n order to begin recovery and avoid complications. adlea may offer additive pain relief and possibly reduce...gery, as well as opioid consumption. The safety of adlea will be evaluated throughout the study. "We now ...

Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy

...led trial will evaluate the efficacy and safety of adlea in reducing post-surgical pain in patients undergo...lea in bunionectomy surgery. "Furthermore, because adlea is administered at the surgical site, its effects ...rast to systemic pain medications such as opioids, adlea appears to avoid potentially serious side effects ...

Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery

... adlea May Provide Pain Relief Without Opiate-Like Side E...surgery, also called Total Hip Arthroplasty (THA). adlea is a long-acting, non-opiate analgesic drug candid...n, chief executive officer of Anesiva. "We believe adlea may help alleviate the resulting pain for patients...

Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery

... adlea May Provide Pain Relief Without Opiate-Like Side E...urgery, also called total knee arthroplasty (TKA). adlea is a long-acting, non-opiate analgesic drug design...e positive preliminary results from our studies of adlea in a number of clinical settings, we believe that...

Adlea in Biological Technology

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) today announced top-line results showing that the Phase 3 trial evaluating Adlea(TM), its long-acting, non-opioid analgesic drug candidate, achieved its primary efficacy endpoint of reducing post-surgica...

Anesiva Receives NASDAQ Delisting Staff Determination Letter

...ment of acute pain following orthopedic surgeries. adlea has been shown in clinical trials to provide exten...Anesiva announced that a Phase 3 clinical trial of adlea achieved its primary efficacy endpoint of reduced ...The trial also met its key secondary endpoint with adlea demonstrating a highly significant reduction in op...

Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones

...esiva's pipeline, Adlea(TM), is currently being evaluated in multiple clinical trials for the management of acute pain following orthopedic surgeries. adlea has been shown in Phase 2 trials to reduce pain after only a single administration for weeks to months in multiple indications for site-specific, acut...

Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer

...ole as we proceed with the clinical development of adlea for the management of acute pain following orthope...ripheral venous access procedures in children, and adlea advancing in clinical development," said Dr. Hough...ment of acute pain following orthopedic surgeries. adlea has been shown in Phase 2 trials to reduce pain af...

Anesiva to Present at BioCentury Newsmakers Conference on September 4, 2008

...nesiva's pipeline, Adlea(TM), is currently being evaluated in Phase 3 clinical trials for the management of acute pain following orthopedic surgeries. adlea has been shown to reduce pain after only a single administration for up to weeks to months in multiple settings based on the results of several mid-st...

Anesiva Announces Second Quarter 2008 Financial Results and Update

...t with Sigma Tau SpA to include most of Europe. adlea -- During the second quarter, Phase 3 enrollment began in a trial of adlea for the management of acute pain following tot...aluate the efficacy and safety of a single dose of adlea or placebo administered prior to closure of th...

Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children

...rrently being evaluated in two pivotal Phase 3 clinical trials to support an indication for the management of acute pain following orthopedic surgery. adlea has been shown to reduce pain after only a single administration for weeks to months in multiple settings in mid-stage clinical trials for site-specif...

Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors

...rrently being evaluated in two pivotal Phase 3 clinical trials to support an indication for the management of acute pain following orthopedic surgery. adlea has been shown to reduce pain after only a single administration for weeks to months in multiple settings in mid-stage clinical trials for site-specif...

Anesiva Announces First Quarter 2008 Financial Results

...also advanced our clinical development program for adlea in the management of acute pain following orthoped...g caused by the very opioids taken to manage pain. adlea addresses the need for improved post-surgical pain... the second quarter launch of Zingo and to advance adlea in Phase 3 trials: Zingo -- In preparation f...

Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook

... "We also have a very active clinical program with adlea that includes two ongoing Phase 2 trials in post-s... -- Continued enrollment in two Phase 2 trials of adlea for post-operative pain associated with orthop...hese trials are investigating a higher dose of adlea that might provide increased efficacy. Anesiva pr...